Patents by Inventor Arduini Arduino

Arduini Arduino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8007993
    Abstract: A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1-100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: August 30, 2011
    Assignee: Sigma—Tau Industrie Farmaceutiche Riunite, S.p.A.
    Inventors: Aureli Tommaso, Arduini Arduino
  • Patent number: 7989158
    Abstract: A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1-100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: August 2, 2011
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Arduini Arduino, Aureli Tommaso
  • Patent number: 7422844
    Abstract: A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1-100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: September 9, 2008
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Arduini Arduino, Aureli Tommaso
  • Publication number: 20080199844
    Abstract: A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1-100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
    Type: Application
    Filed: January 31, 2008
    Publication date: August 21, 2008
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Arduini Arduino, Aureli Tommaso
  • Publication number: 20080166695
    Abstract: A storage solution to maintain and perfuse organs awaiting transplantation comprising (a) an isotonic balanced solution comprising a physiologically acceptable amount of potassium, mono acidic phosphate, biacidic phosphate, chloride, sodium and bicarbonate ions; (b) 50-250 mM glucose; (c) 0.2-20 mM of an alkanoyl L-carnitine or a physiologically acceptable salt thereof; (d) 1 -100 mM of L-carnitine or a physiologically acceptable salt thereof; (e) water is described. The storage solution can also include other components such as anti-oxidants and/or chelating agents.
    Type: Application
    Filed: February 1, 2008
    Publication date: July 10, 2008
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Arduini Arduino, Aureli Tommaso
  • Publication number: 20050054671
    Abstract: Formula (I) compounds are described in which the substituents have the meanings described in the text, and which are useful for the treatment of diseases responding to PPAR? activation, such as heart failure, the hyperlipaemias and atherosclerosis.
    Type: Application
    Filed: January 15, 2003
    Publication date: March 10, 2005
    Inventors: Fabio Giannessi, Tassoni Emanuela, Dell'Uomo Natalina, Sciarroni Anna Floriana, Pessotto Pompeo, Arduini Arduino, Bandera Roma, Tinti Maria Ornella
  • Publication number: 20050032787
    Abstract: Formula (I) compounds are described: Where the groups are as defined here below, and their use as medinies, particularly as serum glucose and serum lipid lowering agents. Said medicines are useful for the prophylaxis and treatment of diabetes, particularly type 2, and its complications, Syndrome X, the various forms of insulin resistance, and hyperlipidaemias, and present reduced side effects, and, particularly, reduced or no liver toxicity.
    Type: Application
    Filed: January 13, 2003
    Publication date: February 10, 2005
    Inventors: Fabio Giannessi, Tassoni Emanuela, Dell'Uomo Natalina, Brunetti Tiziana, Tinti Maria Ornella, Pessotto Pompeo, Arduini Arduino
  • Patent number: 5496821
    Abstract: Solutions which contain L-carnitine and alkanoyl L-carnitine are useful for stabilizing blood for transfusions.
    Type: Grant
    Filed: June 2, 1994
    Date of Patent: March 5, 1996
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Arduini Arduino